Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Cytochrome P450 2C19 Inhibitors [MoA] — Common Side Effects

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Side Effect Total Reports Drugs Deaths Hosp. Life-Threat.
Chronic kidney disease 71,147 7 7,501 6,614 179
Acute kidney injury 39,190 13 5,319 7,681 756
Renal failure 29,952 11 5,231 5,542 277
Drug ineffective 21,779 16 3,314 5,655 1,645
End stage renal disease 20,600 3 4,404 2,821 86
Renal injury 18,962 5 1,694 2,218 36
Off label use 15,824 17 2,289 5,426 1,574
Seizure 9,930 14 248 3,132 292
Gastrooesophageal reflux disease 9,698 10 857 2,064 631
Pain 9,261 16 864 2,611 1,006
Nausea 9,250 17 994 3,095 1,024
Tubulointerstitial nephritis 8,886 6 1,085 1,763 175
Diarrhoea 8,517 17 1,073 3,067 931
Death 8,309 14 8,282 931 107
Headache 8,207 16 872 2,489 852
Fatigue 7,869 15 894 2,325 979
Drug interaction 6,860 13 669 3,045 774
Product use in unapproved indication 6,820 14 957 1,932 753
Vomiting 6,737 17 1,053 2,994 1,083
Dizziness 6,296 16 712 1,876 692
Dyspnoea 6,228 16 985 2,827 891
Condition aggravated 5,780 15 1,216 2,132 860
Nephrogenic anaemia 5,742 2 1,022 1,700 22
Malaise 5,710 15 720 2,339 848
Product use issue 5,218 12 681 1,230 424
Rash 5,130 16 926 1,838 882
Depression 4,902 13 833 1,657 683
Rebound acid hypersecretion 4,851 2 723 582 19
Fall 4,759 13 696 2,936 749
Intentional product misuse 4,720 10 245 984 224
← Back to Cytochrome P450 2C19 Inhibitors [MoA] Compare drugs in this class →